How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
DNA Testing Market
- By Test Type: Ancestry Testing, Health Risk Testing, Carrier Screening, Pharmacogenomics Testing, Paternity Testing, Forensic Testing
- By Application: Clinical Diagnostics, Personal Genomics, Research and Development, Forensic Analysis, Agrigenomics
- By End User: Hospitals and Clinics, Direct-to-Consumer (DTC) Customers, Research Laboratories, Pharmaceutical Companies, Forensic Laboratories
- By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray Analysis, Sanger Sequencing, Massively Parallel Sequencing
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Ancestry Testing leads By Test Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 286 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.171 →
- 11 Company Profiles 16 players: SWOT & benchmarking p.179 →
Full report · locked preview
Everything inside the DNA Testing Market report
A complete, evidence-based study - 11 chapters and 120 sections covering market size, segmentation across 4 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Test Type 6
Application 5
End User 5
Technology 5
Companies profiled
AncestryDNA (Ancestry.com)
23andMe Inc.
MyHeritage Ltd.
Invitae Corporation
Fulgent Genetics Inc.
Gene by Gene Ltd.
BGI Genomics Co. Ltd.
Nebula Genomics
Color Genomics Inc.
Veritas Genetics
CircleDNA (Prenetics)
Living DNA
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →AncestryDNA (Ancestry.com)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →23andMe Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →MyHeritage Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Invitae Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Fulgent Genetics Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Gene by Gene Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →BGI Genomics Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Nebula Genomics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Color Genomics Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Veritas Genetics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →CircleDNA (Prenetics)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Living DNA
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →FamilyTreeDNA
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Helix OpCo
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →LLC
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Dante Labs
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$3,392M by 2033 · 5.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Ancestry Testing44.7
- Health Risk Testing14.4
- Carrier Screening7.9
- Pharmacogenomics Testing11.8
- Paternity Testing11.1
- Forensic Testing10.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$728.1M → $1,021M · 4.3%
Europe$507.5M → $787.7M · 5.6%
Asia Pacific$463.3M → $793.3M · 7.0%
Latin America$286.8M → $491.9M · 7.0%
Middle East and Africa$220.6M → $318.4M · 4.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.472026
5.482027
5.512028
5.522029
5.512030
5.532031
5.552032
5.562033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- AncestryDNA (Ancestry.com)18.3
- 23andMe Inc.13.5
- MyHeritage Ltd.9.0
- Invitae Corporation10.2
- Fulgent Genetics Inc.9.2
- Gene by Gene Ltd.11.9
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Test Type26.4%
Application32.6%
End User31.4%
Technology9.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America29.9
- Europe23.1
- Asia Pacific23.3
- Latin America14.4
- Middle East and Africa9.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| AncestryDNA (Ancestry.com) | 77 | 74 | 96 | 78 | 79 | 80 | 81 |
| 23andMe Inc. | 80 | 71 | 83 | 82 | 88 | 85 | 82 |
| MyHeritage Ltd. | 75 | 71 | 69 | 69 | 73 | 88 | 74 |
| Invitae Corporation | 71 | 65 | 79 | 74 | 77 | 74 | 73 |
| Fulgent Genetics Inc. | 67 | 62 | 77 | 63 | 54 | 68 | 65 |
| Gene by Gene Ltd. | 65 | 70 | 65 | 46 | 67 | 66 | 63 |
| BGI Genomics Co. Ltd. | 45 | 61 | 60 | 54 | 44 | 57 | 54 |
| Nebula Genomics | 56 | 52 | 55 | 51 | 58 | 58 | 55 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- AncestryDNA (Ancestry.com)
- 23andMe Inc.
- MyHeritage Ltd.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| AncestryDNA (Ancestry.com) | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| 23andMe Inc. | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| MyHeritage Ltd. | ✓ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Invitae Corporation | − | ✓ | ✓ | ◐ | ✓ | ◐ |
| Fulgent Genetics Inc. | ◐ | − | ✓ | ◐ | ◐ | ◐ |
| Gene by Gene Ltd. | ◐ | ◐ | ◐ | ◐ | ◐ | − |
| BGI Genomics Co. Ltd. | − | ◐ | − | − | − | ◐ |
| Nebula Genomics | − | − | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →123andMe Inc.82
2AncestryDNA (Ancestry.com)81
3MyHeritage Ltd.74
4Invitae Corporation73
5Fulgent Genetics Inc.65
6Gene by Gene Ltd.63
7Nebula Genomics55
8BGI Genomics Co. Ltd.54
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
AncestryDNA (Ancestry.com)23andMe Inc.
Challenger2
Strong scale, closing on the leaders.
MyHeritage Ltd.Invitae Corporation
Contender2
Focused players with pockets of strength.
Fulgent Genetics Inc.Gene by Gene Ltd.
Niche2
Specialists in a single segment or region.
BGI Genomics Co. Ltd.Nebula Genomics
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Test Type in North America, then scale across DNA Testing Market — a $545M beachhead inside a $7.90B market.
Beachhead (SOM)$545Mobtainable near-term
Serviceable (SAM)$3.01Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Ancestry Testing
Best fit — highest urgency & budget in Test Type.
Economic buyer75 fit
Health Risk Testing
Strong fit — clear ROI and a fast path to value.
End user64 fit
Carrier Screening
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Test Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel28%
Digital / self-serve23%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Test Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win DNA Testing Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified24%
Evaluation14%
Closed-won6%
$14.5KCAC
$52KLTV
3.6:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
DNA Testing Market is a durable-growth opportunity — $2.24B by 2033, compounding at 6.9%.
TAM · 2025$1.31Btoday
TAM · 2033$2.24Bforecast
CAGR6.9%2027–2033
Cumulative$15.6Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.24BTotal addressable market
SAM$793MServiceable available market
SOM$145MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.9% CAGR
Demand compounds through 2033, outpacing GDP across Test Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Test Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.24BLarge & growingTAM by 2033 at 6.9% CAGR
$793MServiceable nowreachable with today’s model
$145MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.74BBear4.5% CAGR
$2.24BBase6.9% CAGR
$2.86BBull9.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
DNA Testing Market — a $8.18B market by 2033. Plan: grow share from 7.6% to 12.4%.
Market size · 2033$8.18Btotal addressable
Market CAGR7.3%2027–2033
Target share12.4%from 7.6% today
Revenue ambition$1.01Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.6% | 12.4% | On track |
| Revenue | $635M | $1.01B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 37.0% | 41.4% | On track |
| Customer retention | 89.8% | 96.6% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Test Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Test Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $110M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Test Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAt risk
- Input-cost & supply riskAt risk
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the DNA Testing Market conversation — a $7.94B market you can size, segment and defend in minutes.
Market size · 2033$7.94Btotal opportunity
Growth9.0%CAGR to 2033
Addressable buyers1,439+accounts in scope
Typical ROI6.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Test Type
Goal Grow share in Test Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.5×return on cost, year one
< 4 mopayback period
$65K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
AncestryDNA (Ancestry.com)23andMe Inc.MyHeritage Ltd.Invitae CorporationFulgent Genetics Inc.Gene by Gene Ltd.BGI Genomics Co. Ltd.Nebula Genomics+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your DNA Testing Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
DNA Testing Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Dna Vaccine Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportDna, Rna, Or Proteins Automatic Purification Systems Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportDNA-Encoded Library Market
Market size, share, segmentation and regional forecast.
$369M market · 2025 base year
View reportDNS & Web Hosting Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportDNV Certified Offshore Containers Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportDOA Plasticizer Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportDoc Cameras Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportDocetaxel Trihydrate Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportDock Boat Lift Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportDock Fender Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportDock Landing Ship Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportDock Leveler Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.